Morgan Stanley Maintains Equal-Weight on Outset Medical, Lowers Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Drew Ranieri maintains an Equal-Weight rating on Outset Medical (NASDAQ:OM) and lowers the price target from $27 to $23.
May 31, 2023 | 11:39 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Equal-Weight rating on Outset Medical and lowers the price target from $27 to $23.
The news directly mentions Outset Medical (NASDAQ:OM) and the lowered price target by Morgan Stanley. This may cause some investors to reevaluate their positions, but the Equal-Weight rating suggests that the stock is still fairly valued. The short-term impact on the stock price is likely to be neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100